Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report

RATIONALE: In estrogen receptor-positive HER2-negative (ER+HER2-) metastatic breast cancer, chemotherapy should be offered only to patients who develop endocrine resistance or have a rapid disease progression. However, the correct sequence of chemotherapy administration is still debated. PATIENT CON...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Barchiesi, Giacomo, Krasniqi, Eriseld, Barba, Maddalena, Giulia, Marina Della, Pizzuti, Laura, Massimiani, Gioia, Ciliberto, Gennaro, Vici, Patrizia
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2019
Matèries:
5750
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6750334/
https://ncbi.nlm.nih.gov/pubmed/31517852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017135
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars